Examining TKI Combinations in Advanced RCC - Episode 1

Frontline Treatment of Advanced Renal Cell Carcinoma

March 30, 2021
Robert J. Motzer, MD

Toni K. Choueiri, MD

Thomas E. Hutson, DO, PharmD

The panelists discuss frontline treatment for renal cell carcinoma, highlighting TKIs targeting VEGFR and the mechanisms of action for currently approved therapeutics.